These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong. Tung CK; Chiang TP; Lam M East Asian Arch Psychiatry; 2012 Mar; 22(1):31-3. PubMed ID: 22447803 [TBL] [Abstract][Full Text] [Related]
23. Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists. Marusich JA; Wiley JL; Lefever TW; Patel PR; Thomas BF Neuropharmacology; 2018 May; 134(Pt A):73-81. PubMed ID: 29113898 [TBL] [Abstract][Full Text] [Related]
24. Cannabinoids for Treatment of MS Symptoms: State of the Evidence. Rice J; Cameron M Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025 [TBL] [Abstract][Full Text] [Related]
25. Spice and all things nasty: the challenge of synthetic cannabinoids. Kalk NJ; Boyd A; Strang J; Finch E BMJ; 2016 Oct; 355():i5639. PubMed ID: 27777237 [No Abstract] [Full Text] [Related]
26. Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis. Fattore L Biol Psychiatry; 2016 Apr; 79(7):539-48. PubMed ID: 26970364 [TBL] [Abstract][Full Text] [Related]
27. Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events. Davidson C; Opacka-Juffry J; Arevalo-Martin A; Garcia-Ovejero D; Molina-Holgado E; Molina-Holgado F Adv Pharmacol; 2017; 80():135-168. PubMed ID: 28826533 [TBL] [Abstract][Full Text] [Related]
28. [Pharmacological properties and dependence liabilities of synthetic cannabinoids]. Funada M Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Jun; 45(3):167-74. PubMed ID: 20681249 [TBL] [Abstract][Full Text] [Related]
39. Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction. Chang X; Bian Y; He Q; Yao J; Zhu J; Wu J; Wang K; Duan T Cell Physiol Biochem; 2017; 42(2):537-550. PubMed ID: 28578322 [TBL] [Abstract][Full Text] [Related]
40. MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors. Irie T; Kikura-Hanajiri R; Usami M; Uchiyama N; Goda Y; Sekino Y Neuropharmacology; 2015 Aug; 95():479-91. PubMed ID: 25747605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]